DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 201 filers reported holding DIPLOMAT PHARMACY INC in Q4 2017. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $8,178,000 | -14.3% | 2,044,470 | +5.0% | 0.00% | 0.0% |
Q3 2019 | $9,542,000 | -17.2% | 1,947,256 | +2.9% | 0.00% | 0.0% |
Q2 2019 | $11,527,000 | -4.9% | 1,892,811 | -9.3% | 0.00% | 0.0% |
Q1 2019 | $12,124,000 | -52.5% | 2,086,832 | +10.0% | 0.00% | -50.0% |
Q4 2018 | $25,528,000 | -25.1% | 1,896,608 | +8.0% | 0.00% | -33.3% |
Q3 2018 | $34,089,000 | -12.6% | 1,756,368 | +15.1% | 0.00% | 0.0% |
Q2 2018 | $39,010,000 | +49.5% | 1,526,119 | +17.8% | 0.00% | +50.0% |
Q1 2018 | $26,096,000 | -11.9% | 1,295,167 | -12.3% | 0.00% | 0.0% |
Q4 2017 | $29,624,000 | +12.7% | 1,476,100 | +16.3% | 0.00% | 0.0% |
Q3 2017 | $26,289,000 | +40.4% | 1,269,360 | +0.3% | 0.00% | 0.0% |
Q2 2017 | $18,718,000 | -5.7% | 1,265,089 | +1.7% | 0.00% | 0.0% |
Q1 2017 | $19,841,000 | +44.5% | 1,244,255 | +14.2% | 0.00% | +100.0% |
Q4 2016 | $13,730,000 | -48.3% | 1,089,708 | +14.8% | 0.00% | -66.7% |
Q3 2016 | $26,576,000 | -22.5% | 948,965 | -3.1% | 0.00% | -25.0% |
Q2 2016 | $34,301,000 | +41.0% | 979,821 | +10.3% | 0.00% | +33.3% |
Q1 2016 | $24,331,000 | +0.0% | 888,040 | +24.9% | 0.00% | 0.0% |
Q4 2015 | $24,323,000 | +24.6% | 710,800 | +4.6% | 0.00% | +50.0% |
Q3 2015 | $19,516,000 | -27.0% | 679,362 | +13.8% | 0.00% | -33.3% |
Q2 2015 | $26,716,000 | +22.6% | 596,999 | -5.3% | 0.00% | +50.0% |
Q1 2015 | $21,799,000 | +395.4% | 630,357 | +291.9% | 0.00% | – |
Q4 2014 | $4,400,000 | – | 160,837 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|